LabCorp Envigo deal will see both companies focus and expand respective expertise

LabCorp, Envigo deal will see both companies focus and expand respective expertise

12:53 EDT 23 Apr 2019 | Outsourcing-Pharma

LabCorpâs Covance Drug Development segment is set to acquire Envigoâs nonclinical research services business for $485m â while Envigo will purchase Covanceâs research products business.

More From BioPortfolio on "LabCorp, Envigo deal will see both companies focus and expand respective expertise"